AMN Healthcare Services (AMN) FY2014 results: revenue $1.0 billion, up 2.4% on the year
AMN Healthcare Services Inc. (AMN) reported revenue of $1.0 billion for fiscal 2014, the year ended 31 December 2014, up 2.4% on the year before. Net income was $33 million, up 0.9%, and diluted earnings per share $0.69. The figures are the company's own, from the 10-K it filed with the SEC on 25 February 2015.
Revenue
$1.0 billion
+2.4% on the year
FY2009FY2014
Operating margin
6.6%
6.5% a year earlier
FY2009FY2014
Net income
$33 million
+0.9% on the year
FY2009FY2014
Diluted EPS
$0.69
0.0% on the year
FY2009FY2014
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Revenue
1,036
1,012
954
+2.4%
Cost of revenue
720
715
684
+0.8%
Gross profit
316
297
270
+6.3%
Gross margin
30.5%
29.4%
28.3%
Selling, general and administrative
232
218
203
+6.4%
Operating income
67.9
65.5
53.3
+3.7%
Operating margin
6.6%
6.5%
5.6%
Interest expense
9.2
9.7
26.0
-4.4%
Pre-tax income
58.7
55.8
27.3
+5.1%
Income tax
25.4
22.9
11.0
+11.1%
Effective tax rate
43.4%
41.0%
40.3%
Net income
33.2
32.9
17.1
+0.9%
Net margin
3.2%
3.3%
1.8%
Diluted EPS
$0.69
$0.69
$0.37
0.0%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Operating cash flow
27.7
60.2
58.4
-54.0%
Capital expenditure
19.1
9.0
5.5
+111.5%
Free cash flow
8.5
51.1
52.9
-83.3%
Free cash flow margin
0.8%
5.1%
5.5%
Cash from investing
-28.2
-49.2
1.6
Cash from financing
-2.1
-1.0
-58.2
Depreciation and amortisation
16.0
13.5
14.2
+18.1%
Share-based compensation
7.2
6.1
6.2
+16.8%
Buybacks
0.0
n/a
n/a
Diluted shares, weighted
48m
48m
47m
+0.6%
Shares outstanding at period end
47m
46m
46m
+1.4%
Balance sheet
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Shareholders' equity
257
218
182
+17.8%
Redeemable equity
n/a
n/a
0.0
Debt
161
159
160
+1.6%
Other liabilities
264
228
176
+15.9%
Total liabilities and equity
682
604
517
+12.8%
Fixed assets
32.9
21.2
14.8
+55.4%
Goodwill
154
145
123
+6.7%
Intangible assets
153
150
137
+1.5%
Cash and equivalents
13.1
15.6
5.7
-16.1%
Receivables
186
147
143
+26.3%
Other assets
143
125
94.1
+14.0%
Total assets
682
604
517
+12.8%
10-K for the year ended 31 December 2014, filed 25 February 2015: the filing.